Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Letter From The Editor Previous | All Articles This Week | Next
This article originally posted 10 January, 2012 and appeared in  Safety and Error PreventionDiabetes Clinical Mastery Series Issue 66

Editor's Note DCMS #66: Beware of Similar Medication Names

Last week I was walking in the OTC department in front of the pharmacy and I noticed a box of Fastin on the shelf. I was surprised by this as I knew that the RX version was phentermine 37.5 mg and could not believe that you could now buy it over the counter. I picked up the box and the ingredients were not the same: an OTC supplement maker had bought the rights to the name and was using it. It was not until we received this week's Disaster Averted, Beware of Similar Names, that I fully realized the potential problems that this could cause.

Our Homerun Slides from Stan Schwartz, MD, FACE, FACP, Emeritus Clinical Associate Professor of Medicine, University of Pa., continues to expand on the basis for an Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes with Part 3 of this series, and our Clinical Gem focuses on Individual Interventions and Motivational Interviewing.

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 10 January, 2012 and appeared in  Safety and Error PreventionDiabetes Clinical Mastery Series Issue 66

Past five issues: Diabetes Clinical Mastery Series Issue 137 | Issue 677 | SGLT2 Special Edition Issue 2 | Diabetes Clinical Mastery Series Issue 136 | Issue 676 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
What test do you use to screen for prediabetes?

Navigate Diabetes In Control
Search Articles On Diabetes In Control